Nintedanib Monthly Treatment Cost Overview
Nintedanib (Nintedanib) is a drug that targets tyrosine kinases and is widely used to treat a variety of lung diseases such as idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung disease (ILD), and systemic sclerosis-associated interstitial lung disease (SSc-ILD). Patients should follow the doctor's prescription when using this drug. The usual recommended dose is 150mg, taken twice a day, about 12 hours apart, and it is recommended to take it with food to improve the bioavailability of the drug. In addition, the patient's total daily dose should not exceed 300 mg.
In the Chinese market, nintedanib is usually packaged in two specifications: 100 mg 30 capsules and 150 mg 30 capsules. At present, the market price of 150mg specifications is generally around 4,000 yuan. Based on this price, a patient's monthly medication needs roughly two boxes, so the overall cost may be close to 8,000 yuan. However, actual costs may vary based on factors such as regional differences, pharmacy pricing, and Medicare reimbursement policies.

In the international market, the original drug of nintedanib is mainly produced by Bayer in Germany. Common specifications are:100mg 60 tablets and 150mg 60 tablets. For example, when purchased in places such as Türkiye or India, the price is usually between 4,000 and 5,000 yuan (note that exchange rate fluctuations may cause price changes). According to the recommended dosage, patients only need one box per month, which makes the original drugs on the international market relatively more economical in terms of cost.
In addition, there are several generic drug options on the market. The ingredients of generic drugs are basically similar to the original drugs. For example, the price of 150mg*30 tablets of generic drugs produced in Laos is usually around 600 yuan (also affected by the exchange rate). The introduction of generic drugs provides another feasible option for patients with limited financial conditions, especially when long-term medication is required, which can significantly reduce the cost of treatment.
Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da1c9f37-779e-4682-816f-93d0faa4cfc9##
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)